PDX models play a significant role in the development of new cancer therapies. They are used to: - Screen Potential Drugs: Assess the efficacy of new drugs before clinical trials. - Study Drug Resistance: Understand mechanisms behind resistance to current treatments. - Biomarker Identification: Discover biomarkers that can predict treatment response. - Combination Therapies: Evaluate the effectiveness of drug combinations.
